News Author: Jen Smith Publish date: April 25, 2015
PHILADELPHIA—A drug that has fallen short of expectations in clinical trials of prostate cancer may be effective for treating multiple myeloma (MM), a...
News Author: Jen Smith Publish date: April 24, 2015
PHILADELPHIA—Withholding treatment from chronic lymphocytic leukemia (CLL) patients because they are of advanced age and have comorbidities may not be...
News Author: Jen Smith Publish date: February 25, 2015
Photo by Chad McNeeley
SAN DIEGO—Haploidentical bone marrow transplant (haplo-BMT) is a feasible option for patients with high-risk hematologic mal...
News Author: Jen Smith Publish date: February 24, 2015
Photo courtesy of Canterbury
District Health Board
SAN DIEGO—New research indicates that older stem cell donors have somewhat poorer overall healt...
News Author: Jen Smith Publish date: February 20, 2015
Photo courtesy of CDC
SAN DIEGO—Ibrutinib can produce favorable results in heavily pretreated patients with chronic lymphocytic leukemia (CLL) who ...
News Author: Jen Smith Publish date: February 19, 2015
Photo by Chad McNeeley
SAN DIEGO—A retrospective study has revealed a few factors that may predict outcomes of allogeneic hematopoietic stem cell t...
News Author: Jen Smith Publish date: February 18, 2015
Photo courtesy of NHS
SAN DIEGO—A product that promotes CD34 expansion has solved the problem of poor engraftment associated with umbilical cord bl...
News Author: Jen Smith Publish date: February 17, 2015
Photo by Rhoda Baer
SAN DIGEO—A phase 3 study comparing conditioning regimens in multiple myeloma patients undergoing autologous transplant h...
News Author: Jen Smith Publish date: February 10, 2015
Photo by Larry Young
SAN FRANCISCO—Adding romidepsin to CHOP can enhance the regimen’s efficacy against peripheral T-cell lymphoma (PTCL), but the ...
News Author: Jen Smith Publish date: February 9, 2015
Photo by Larry Young
SAN FRANCISCO—Two phase 2 studies testing mogamulizumab in peripheral T-cell lymphomas (PTCLs) suggest that higher response ra...
News Author: Jen Smith Publish date: February 5, 2015
Photo by Larry Young
SAN FRANCISCO—MicroRNA-155 (miR-155) can act as an oncogenic driver in ALK− anaplastic large-cell lymphoma (ALCL) and may ther...
News Author: Jen Smith Publish date: February 4, 2015
Photo by Larry Young
SAN FRANCISCO—Preclinical and early phase 1 results suggest the aurora A kinase inhibitor alisertib and the histone deacetylas...
News Author: Jen Smith Publish date: February 3, 2015
Photo by Larry Young
SAN FRANCISCO—The histone deacetylase (HDAC) inhibitor chidamide is effective and well-tolerated in patients with relapsed or ...
News Author: Jen Smith Publish date: February 2, 2015
Photo by Larry Young
SAN FRANCISCO—Outcomes remain dismal for the majority of patients with peripheral T-cell lymphoma (PTCL), according to a speak...
News Author: Jen Smith Publish date: February 2, 2015
Photo by Larry Young
SAN FRANCISCO—The distribution of peripheral T-cell lymphoma (PTCL) subtypes in the US varies greatly according to race and et...
